Entity
  • Leuko

    Created in 2017
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    433 1,657
  • Activities

  • Technologies

  • Entity types

  • Location

    8 St Mary's St, Boston, MA 02215, USA

    Boston

    United States of America

  • Employees

    Scale: 11-50

    Estimated: 16

  • Engaged corporates

    4
    3 1
  • Added in Motherbase

    5 years, 6 months ago
Description
  • Value proposition

    Non-invasive white blood cell monitoring

    Leuko is developing the first non-invasive white blood cell device. White blood cell assessment is a first-line indicator for various medically-relevant situations, ranging from chemotherapy management to the detection of life threatening infections worldwide. This test is currently invasive and not readily accessible - it requires patient travel, blood draws and laboratory infrastructure. Based on MIT research, Leuko is re-imagining the way to perform these tests without extracting blood and in a portable device.

    Medical Devices, Diagnostics, Medical Technology, Clinical Imaging, and Bioengineering

Corporate interactions BETA
Corporate TypeTweets Articles
GSK
GSK
Pharmaceutical, Pharmaceutical Manufacturing
GSK
Pharmaceutical, Pharmaceutical Manufacturing
Other

29 Feb 2024


Fresenius Medical Care
Fresenius Medical Care
Pharmaceutical, Hospitals and Health Care
Fresenius Medical Care
Pharmaceutical, Hospitals and Health Care
Other

11 May 2018


Impact Hub
Impact Hub
Startup accelerator & VC, Civic and Social Organizations
Impact Hub
Startup accelerator & VC, Civic and Social Organizations
Other

7 Apr 2016


MassChallenge
MassChallenge
Startup accelerator & VC, Venture Capital and Private Equity Principals
MassChallenge
Startup accelerator & VC, Venture Capital and Private Equity Principals
Not capitalistic
Partnership
Event

24 Jun 2020


Similar entities
Loading...
Loading...
Social network dynamics